Eton projects revenue to exceed $120M in 2026 as it targets a 50% adjusted EBITDA margin by 2028
Eton Pharmaceutcials, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $28.68
+14% in 3d after detection
Post-detection moves
1h
—
1d
+7.4%
3d
+14%
7d
+7.1%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS